Actinomycetes as nature’s pharmacists

L T Fernandez-Martinez

Research output: Contribution to specialist publicationArticle (specialist)


The increasing incidence of antibiotic-resistant bacterial pathogens has resulted in an urgent need for new, clinically useful antibiotics. By 2050, antibiotic-resistant micro-organisms are expected to cause more deaths than cancer, road traffic accidents and other chronic diseases worldwide.

This is partly because effective antibiotics are essential to prevent infection when carrying out life-saving medical procedures such as surgery and chronic illness management. While reduction of antimicrobial use in farming and increased antibiotic stewardship are both essential, new viable alternative drugs that can be used in the clinic are still required.
Original languageEnglish
VolumeNovember 2019
Specialist publicationMicrobiology Today
Publication statusPublished - 5 Nov 2019


  • actinomycetes
  • antibiotic production
  • Antibiotic resistance


Dive into the research topics of 'Actinomycetes as nature’s pharmacists'. Together they form a unique fingerprint.

Cite this